Nitration of soluble proteins in organotypic culture models of Parkinson's disease

Neurochemistry International

Volumn 52, Issue 3, 2008, Pages 487-494

  Larsen, Trine R ^a   Söderling, Ann Sofi ^b   Caidahl, Kenneth ^b,c   Roepstorff, Peter ^a   Gramsbergen, Jan Bert ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1 Methyl 4 phenylpyridinium; 3 Nitrotyrosine; Dopamine; Mass spectrometry; Nitric oxide; Rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 NITROTYROSINE; DOPA; DOPAMINE; LINSIDOMINE; N(G) NITROARGININE METHYL ESTER; NOMIFENSINE; ROTENONE;

ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESENCEPHALON; MOUSE; NITRATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MICE; MICE, INBRED C57BL; NEUROCHEMISTRY; NEUROTOXINS; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEINS; PTERINS; REACTIVE NITROGEN SPECIES; SUBSTANTIA NIGRA; TYROSINE; TYROSINE 3-MONOOXYGENASE; UNCOUPLING AGENTS;

EID: 38049051733     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.08.008     Document Type: Article

References (39)

1. Abreu-Gonzalez P., Gonzalez-Hernandez T., Afonso-Oramas D., Cruz-Muros I., Barroso-Chinea P., and Gonzalez M.C. Tetrahydrobiopterin stimulates l-DOPA release from striatal tissue. Eur. J. Pharmacol. 541 (2006) 33-37
2. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti R.R., Horwitz J., and Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 7659-7663
3. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
4. Blanchard-Fillion B., Souza J.M., Friel T., Jiang G.C., Vrana K., Sharov V., Barron L., Schoneich C., Quijano C., Alvarez B., Radi R., Przedborski S., Fernando G.S., Horwitz J., and Ischiropoulos H. Nitration and inactivation of tyrosine hydroxylase by peroxynitrite. J. Biol. Chem. 276 (2001) 46017-46023
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
6. Cutillas B., Espejo M., and Ambrosio S. 7-Nitroindazole prevents dopamine depletion caused by low concentrations of MPP+ in rat striatal slices. Neurochem. Int. 33 (1998) 35-40
7. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 259-272
8. Good P.F., Hsu A., Werner P., Perl D.P., and Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57 (1998) 338-342
9. Gramsbergen J.B., Sandberg M., Moller Dall A., Kornblit B., and Zimmer J. Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin. Brain Res. 935 (2002) 47-58
10. Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R.T., and Beal M.F. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons [see comments]. Nat. Med. 2 (1996) 1017-1021
11. Hoglinger G.U., Feger J., Prigent A., Michel P.P., Parain K., Champy P., Ruberg M., Oertel W.H., and Hirsch E.C. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84 (2003) 491-502
12. Hornykiewicz O., and Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45 (1987) 19-34
13. Hyun D.H., Lee M., Halliwell B., and Jenner P. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J. Neurochem. 86 (2003) 363-373
14. Ischiropoulos H., and Beckman J.S. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J. Clin. Invest. 111 (2003) 163-169
15. Ischiropoulos H., Duran D., and Horwitz J. Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. J. Neurochem. 65 (1995) 2366-2372
16. Jakobsen B., Gramsbergen J.B., Moller Dall A., Rosenblad C., and Zimmer J. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF. Eur. J. Neurosci. 21 (2005) 2939-2948
17. Katsuki H., Tomita M., Takenaka C., Shirakawa H., Shimazu S., Ibi M., Kume T., Kaneko S., and Akaike A. Superoxide dismutase activity in organotypic midbrain-striatum co-cultures is associated with resistance of dopaminergic neurons to excitotoxicity. J. Neurochem. 76 (2001) 1336-1345
18. Kaur H., Lyras L., Jenner P., and Halliwell B. Artefacts in HPLC detection of 3-nitrotyrosine in human brain tissue. J. Neurochem. 70 (1998) 2220-2223
19. Kuhn D.M., and Geddes T.J. Tetrahydrobiopterin prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide. Mol. Pharmacol. 64 (2003) 946-953
20. Kuhn D.M., Sakowski S.A., Sadidi M., and Geddes T.J. Nitrotyrosine as a marker for peroxynitrite-induced neurotoxicity: the beginning or the end of the end of dopamine neurons?. J. Neurochem. 89 (2004) 529-536
21. Kuhn D.M., Sadidi M., Liu X., Kreipke C., Geddes T., Borges C., and Watson J.T. Peroxynitrite-induced nitration of tyrosine hydroxylase: identification of tyrosines 423, 428, and 432 as sites of modification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tyrosine-scanning mutagenesis. J. Biol. Chem. 277 (2002) 14336-14342
22. Larstad M., Söderling A.S., Caidahl K., and Olin A.C. Selective quantification of free 3-nitrotyrosine in exhaled breath condensate in asthma using gas chromatography/tandem mass spectrometry. Nitric Oxide 13 (2005) 134-144
23. Mackenzie G.M., Jackson M.J., Jenner P., and Marsden C.D. Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset. Synapse 26 (1997) 301-316
24. Madsen J.T., Jansen P., Hesslinger C., Meyer M., Zimmer J., and Gramsbergen J.B. Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures. J. Neurochem. 85 (2003) 214-223
25. Manabe Y., Wang J.M., Murakami T., Warita H., Hayashi T., Shoji M., and Abe K. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite. J. Neurosci. Res. 65 (2001) 371-377
26. Mishizen-Eberz A.J., Norris E.H., Giasson B.I., Hodara R., Ischiropoulos H., Lee V.M., Trojanowski J.Q., and Lynch D.R. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry 44 (2005) 7818-7829
27. Nakamura K., Bindokas V.P., Kowlessur D., Elas M., Milstien S., Marks J.D., Halpern H.J., and Kang U.J. Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons. J. Biol. Chem. 276 (2001) 34402-34407
28. Park S., Geddes T.J., Javitch J.A., and Kuhn D.M. Dopamine prevents nitration of tyrosine hydroxylase by peroxynitrite and nitrogen dioxide: is nitrotyrosine formation an early step in dopamine neuronal damage?. J. Biol. Chem. 278 (2003) 28736-28742
29. Paxinou E., Chen Q., Weisse M., Giasson B.I., Norris E.H., Rueter S.M., Trojanowski J.Q., Lee V.M., and Ischiropoulos H. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21 (2001) 8053-8061
30. Przedborski S., and Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov. Disord. 13 (1998) 35-38
31. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V.L., and Dawson T.M. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4565-4571
32. Ryberg H., Söderling A.S., Davidsson P., Blennow K., Caidahl K., and Persson L.I. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease. Neurochem. Int. 45 (2004) 57-62
33. Schulz J.B., Matthews R.T., Muqit M.M., Browne S.E., and Beal M.F. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64 (1995) 936-939
34. Schwedhelm E., Tsikas D., Gutzki F.M., and Frolich J.C. Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state. Anal. Biochem. 276 (1999) 195-203
35. Sherer T.B., Betarbet R., Stout A.K., Lund S., Baptista M., Panov A.V., Cookson M.R., and Greenamyre J.T. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22 (2002) 7006-7015
36. Söderling A.S., Ryberg H., Gabrielsson A., Larstad M., Toren K., Niari S., and Caidahl K. A derivatization assay using gas chromatography/negative chemical ionization tandem mass spectrometry to quantify 3-nitrotyrosine in human plasma. J. Mass Spectrom. 38 (2003) 1187-1196
37. Souza J.M., Giasson B.I., Chen Q., Lee V.M., and Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 275 (2000) 18344-18349
38. Viera L., Ye Y.Z., Estevez A.G., and Beckman J.S. Immunohistochemical methods to detect nitrotyrosine. Methods Enzymol. 301 (1999) 373-381
39. Yamamoto T., Maruyama W., Kato Y., Yi H., Shamoto-Nagai M., Tanaka M., Sato Y., and Naoi M. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J. Neural Transm. 109 (2002) 1-13